Trial Details

COMPLETED
Basic Information
Clinical ID c767
Identifier NCT06082986
Trial Title A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Xian-Janssen Pharmaceutical Ltd.
City Zhejiang
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2023-10-09
Primary Completion Date 2024-06-05
Completion Date 2024-06-05